Novozymes A/S (OTCMKTS:NVZMF – Get Free Report) is anticipated to issue its results before the market opens on Thursday, November 5th. Analysts expect the company to announce earnings of $0.7510 per share and revenue of $1.29 billion for the quarter.
Novozymes A/S Price Performance
NVZMF opened at $70.08 on Thursday. Novozymes A/S has a fifty-two week low of $52.10 and a fifty-two week high of $73.07. The company’s 50-day moving average is $67.37 and its 200 day moving average is $62.09.
About Novozymes A/S
Novozymes A/S was a Denmark-based biotechnology company specializing in enzymes, microorganisms and other biological solutions. Its products were designed to improve industrial processes and support more sustainable production across areas including food and beverages, household care, agriculture, bioenergy and technical applications.
The company developed and commercialized biological products used in applications such as baking, brewing, animal nutrition, crop production, laundry and cleaning, textiles, biofuels and wastewater treatment.
Further Reading
- Five stocks we like better than Novozymes A/S
- Boeing Got Its MAX 10 Approval, But Q3 Delivered a Reality Check
- The Invisible AI Backbone: Corning’s AI Fiber Play
- Heavy Metal: Why Nucor Could Be an Overlooked AI Infrastructure Winner
- Why Tesla’s Upside Is About More Than a SpaceX Merger
Receive News & Ratings for Novozymes A/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Novozymes A/S and related companies with MarketBeat.com's FREE daily email newsletter.
